↓ Skip to main content

Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus

Overview of attention for article published in Arthritis Research & Therapy, April 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
5 patents

Citations

dimensions_citation
68 Dimensions

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus
Published in
Arthritis Research & Therapy, April 2010
DOI 10.1186/ar2887
Pubmed ID
Authors

Yihong Yao, Brandon W Higgs, Laura Richman, Barbara White, Bahija Jallal

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 1%
United States 1 1%
Australia 1 1%
Unknown 64 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 33%
Student > Postgraduate 8 12%
Student > Ph. D. Student 7 10%
Other 6 9%
Student > Doctoral Student 5 7%
Other 10 15%
Unknown 9 13%
Readers by discipline Count As %
Medicine and Dentistry 25 37%
Agricultural and Biological Sciences 13 19%
Biochemistry, Genetics and Molecular Biology 9 13%
Immunology and Microbiology 5 7%
Computer Science 2 3%
Other 3 4%
Unknown 10 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 November 2022.
All research outputs
#5,447,195
of 25,374,917 outputs
Outputs from Arthritis Research & Therapy
#1,264
of 3,381 outputs
Outputs of similar age
#22,386
of 102,764 outputs
Outputs of similar age from Arthritis Research & Therapy
#16
of 38 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 102,764 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.